Insight Molecular Diagnostics Inc (IMDX)

May 17, 2026

Insight Molecular Diagnostics Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:IMDX) 2026-05-17 - Seeking Alpha

May 17, 2026

May 15, 2026

Lake Street Remains a Buy on Insight Molecular Diagnostics (IMDX) - The Globe and Mail

May 15, 2026

May 15, 2026

How Insight Molecular Diagnostics (IMDX) Story Is Shifting With Fresh Capital And GraftAssureDx Submission - Yahoo Finance

May 15, 2026

May 15, 2026

BTIG reiterates Neutral on Insight Molecular stock amid FDA review By Investing.com - Investing.com Australia

May 15, 2026

May 15, 2026

BTIG reiterates Neutral on Insight Molecular stock amid FDA review - Investing.com

May 15, 2026

May 15, 2026

Insight Molecular Q1 2026 Earnings Call Transcript - Sahm

May 15, 2026

May 15, 2026

We're Keeping An Eye On Insight Molecular Diagnostics' (NASDAQ:IMDX) Cash Burn Rate - Sahm

May 15, 2026

May 14, 2026

Lake Street Maintains Insight Molecular Diagnostics(IMDX.US) With Buy Rating, Maintains Target Price $12 - Moomoo

May 14, 2026

May 14, 2026

Insight Molecular Diagnostics Inc (IMDX) Q1 2026 Earnings Call H - GuruFocus

May 14, 2026

May 14, 2026

Insight Molecular Diagnostics (IMDX) Sees Positive Engagement wi - GuruFocus

May 14, 2026

May 13, 2026

Insight Molecular Diagnostics expects about $0.25M Q2 2026 revenue while projecting second-quarter cash burn above $9M - MSN

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics (IMDX) Q1 2026 Earnings: EPS not d - GuruFocus

May 13, 2026

May 13, 2026

Insight Molecular Diagn 1Q Rev $32,000 >IMDX - Moomoo

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2026

May 13, 2026

Earnings call transcript: Insight Molecular Diagnostics Q1 2026 sees stock rise 2.41% - Investing.com Australia

May 13, 2026

May 13, 2026

IMDX Q1 2026 Earnings Call Transcript - The Globe and Mail

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics Inc Q1 Net Income USD -4.29 Million - TradingView

May 13, 2026

May 13, 2026

Insight Molecular Diagn 1Q Loss/Shr 12c >IMDX - Moomoo

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics : Investor Deck (imdx investor presentation may 2026) - marketscreener.com

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics Q1 loss narrows as costs drop - TradingView

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics: Q1 Earnings Snapshot - crossville-chronicle.com

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics (NASDAQ: IMDX) Q1 2026 revenue collapses to $32K as losses narrow - Stock Titan

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com

May 13, 2026

May 13, 2026

IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization - The Manila Times

May 13, 2026

May 13, 2026

[8-K] Insight Molecular Diagnostics Inc. Reports Material Event - Stock Titan

May 13, 2026

May 13, 2026

[8-K/A] Insight Molecular Diagnostics Inc. Amends Material Event Report - Stock Titan

May 13, 2026

May 13, 2026

Press Release: IMDX Reports Q1 2026 Results and Update on Progress Toward GraftAssure Commercialization - Moomoo

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics Inc. Q1 earnings preview - MSN

May 13, 2026

May 13, 2026

Insight Molecular Diagnostics Inc (IMDX) Q1 2026 Earnings Call Highlights: Strategic Advances ... By GuruFocus - Investing.com Canada

May 13, 2026

May 12, 2026

MSN Money - MSN

May 12, 2026

May 12, 2026

IMDX SEC FilingsInsight Molecular Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan

May 12, 2026

May 11, 2026

Insight Molecular Diagnostics Inc expected to post a loss of 26 cents a shareEarnings Preview - TradingView

May 11, 2026

May 11, 2026

Number of shareholders of Insight Molecular Diagnostics Inc. – NASDAQ:IMDX - TradingView

May 11, 2026

May 08, 2026

Insight Molecular Diagnostics Inc. (IMDX) - Zacks Investment Research

May 08, 2026

May 08, 2026

Alpha Buying: Insider Conviction in High-Risk Biotech - Sahm

May 08, 2026

May 07, 2026

Earnings Preview: IMDX to Report Financial Results Post-market on May 13 - Moomoo

May 07, 2026

May 06, 2026

iMDx will post quarterly results May 13, then take investor questions live - Stock Titan

May 06, 2026

May 06, 2026

Analysts Offer Insights on Healthcare Companies: GeneDx Holdings (WGS), Pfizer (PFE) and Travere Therapeutics (TVTX) - The Globe and Mail

May 06, 2026

Apr 30, 2026

Insight Molecular Corrects Bylaws Disclosure in Annual Report - TipRanks

Apr 30, 2026

Apr 30, 2026

IMDX (NASDAQ: IMDX) outlines 2026 proxy votes, FDA dd-cfDNA strategy - Stock Titan

Apr 30, 2026

Apr 28, 2026

How The Insight Molecular Diagnostics (IMDX) Story Is Shifting With Funding And GraftAssureDx Milestones - Yahoo Finance

Apr 28, 2026

Apr 27, 2026

Broadwood Partners, Neal C. Bradsher buy $2.03m of Insight Molecular Diagnostics - Investing.com India

Apr 27, 2026

Apr 27, 2026

Broadwood and Neal Bradsher hold 39.7% of Insight Molecular (IMDX) shares - Stock Titan

Apr 27, 2026

Apr 27, 2026

Broadwood entities add 570K IMDX shares, hold 12.7M plus warrants - Stock Titan

Apr 27, 2026

Apr 27, 2026

Insight Molecular Diagnostics Inc. Q4 2025 earnings preview - MSN

Apr 27, 2026

Apr 26, 2026

Insight Molecular Diagnostics prices $26M registered direct offering; shares down - MSN

Apr 26, 2026